{{Taxobox
| color = lightblue
| name = ''Filobasidiella neoformans''
| image = Cryptococcosis of lung in patient with AIDS. Mucicarmine stain 962 lores.jpg
| image_caption = ''Filobasidiella neoformans'' в легенях пацієнта на СНІД. Капсула дріжджів забарвлена червоним.
| image_width = 250px
| domain = Еукаріоти (Eukaryota)
| regnum = Гриби (Fungi)
| subregnum = Вищі гриби (Dikarya)
| divisio = Базидіоміцети&nbsp;(Basidiomycota)
| subdivisio = Agaricomycotina
| classis = Heterobasidiomycetes
| ordo = Tremellales
| familia = Tremellaceae
| genus = ''Filobasidiella''
| species = '''''Filobasidiella neoformans'''''
| binomial = ''Filobasidiella neoformans''
| synonyms = ''Cryptococcus neoformans''
| ncbi = 5206
}}
'''''Filobasidiella neoformans''''' (інкапсульованих дріжджеподібних грибів, що може жити в тілі як тварин, так і рослин. Цей вид належить до відділу базидіоміцетів. ''F. neoformans'' зазвичай росте як розмножується за допомгою гіфи і рости як волокнистий грибок<ref>Мікрофотографі проекту [http://tolweb.org/tree/phylogeny.html Tree of Life project] надана [http://www.dumru.mc.duke.edu/ Відділом мікології Duke University]; зображення є частиною статті [http://tolweb.org/tree?group=Hymenomycetes&contgroup=Basidiomycota Hymenomycetes]. Отримано 2005-03-15.</ref>. Під час росту у формі дріжджів, ''F. neoformans'' формує помітну капсулу, сформовану здебільшого з полісахаридів, яка може бути легко візуалізована за допомогою туші. Частинки пігменту не проникають до капсули, ака оточує сферичні дріжджові клітини, приводячи утворення зони очищення або «ореолу» навколо клітин.

''F. neoformans'' є опортуністичним патогеном людини і може викликати криптококкоз.

{{Taxobox
| name = ''Cryptococcus neoformans''
| regnum = Fungi
| phylum = Basidiomycota
| subphylum = Basidiomycotina
| ordo = Sporidiales
| familia = Sporidiobolaceae
| genus = Filobasidiella (''Cryptococcus'')
| species = '''''Filobasidiella neoformans <br>(Cryptococcus neoformans)'''''
}}

'''''Cryptococcus neoformans''''' is an encapsulated yeast-like Division Basidiomycota, which is one the five major types of fungi.  ''C. neoformans'' usually grows as a yeast (unicellular) and replicates by budding.  Under certain conditions, both in nature and in the laboratory, ''C. neoformans'' can grow as a filamentous fungus as pictured here: [http://tolweb.org/tree/ToLimages/Filobasidiella_neoformans.jpg picture of the organism]<ref>Photomicrograph hosted by the [http://tolweb.org/tree/phylogeny.html Tree of Life project] and specifically contributed by the [http://www.dumru.mc.duke.edu/ Duke University Mycology Research Unit]; the picture is part of the [http://tolweb.org/tree?group=Hymenomycetes&contgroup=Basidiomycota Hymenomycetes article].  Retrieved 2005-03-15</ref>.  When grown as a yeast, ''C. neoformans'' has a prominent capsule composed mostly of polysaccharides.  Microscopically, the India ink stain is used for easy visualization of the capsule.  The particles of ink pigment do not enter the capsule that surrounds the spherical yeast cell, resulting in a zone of clearance or "halo" around the cells.
thumb|right|250px|'''Cryptococcus neoformans''' seen in the lung of a patient with AIDS. The inner capsule of the organism stains red in this photomicrograph
The species ''C. neoformans'' is composed of three variants (v.): ''C. neoformans v. gattii'', ''v. grubii'', and ''v. neoformans''.  ''C. neoformans v. gattii'' is found mostly in the melted down reactor harvest energy of radiation (primary beta radiation from caesium-137) itself.<ref></ref>   

Infection with ''C. neoformans'' is termed cryptococcosis. Meningitis, especially as a secondary infection for AIDS patients, is often caused by ''C. neoformans''.

==Treatment==
Cryptococcosis that does not affect the central nervous system can be treated with fluconazole alone.

Cryptococcal meningitis should be treated for two weeks with intravenous Amphotericin B 0.7&ndash;1.0 (mg/kg)/day and oral flucytosine 100 (mg/kg)/day (or intravenous flucytosine 75 (mg/kg)/day if the patient is unable to swallow).  This should then be followed by oral fluconazole 200mg daily for ten weeks<ref></ref> and then 200 mg daily until the patient's CD4 count is above 100 for three months and his HIV viral load is undetectable.<ref>{{cite journal | title=Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy
 | journal=AIDS | volume=14 | issue=16 | year=2000 | pages=2615&ndash;26 | author=Martínez E, García-Viejo MA, Marcos MA, ''et al.''|pmid=11101078 | doi=10.1097/00002030-200011100-00029 }}</ref><ref>{{cite journal | title=Discontinuation of secondary prophylaxis for Cryptococcal meningitis in Human Immunodeficiency Virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study | author=Vibhagool A, Sungkanuparph S, Mootsikapun P, ''et al.'' | journal=Clin Infect Dis | volume=36 | year=2003 | pages=1329&ndash;31 |
doi=10.1086/374849 | pmid=12746781 }}</ref>